methylphenidate

(redirected from Daytrana)
Also found in: Dictionary, Medical, Wikipedia.
Related to Daytrana: methylphenidate, Concerta, Focalin
Graphic Thesaurus  🔍
Display ON
Animation ON
Legend
Synonym
Antonym
Related
  • noun

Synonyms for methylphenidate

central nervous system stimulant (trade name Ritalin) used in the treatment of narcolepsy in adults and attention deficit disorder in children

References in periodicals archive ?
The increase in both depreciation and amortization is primarily due to the inclusion of a full year's amortization and depreciation charge in respect of assets acquired through the TKT acquisition, together with the amortization of capitalized milestone payments for DAYTRANA following its launch in June 2006.
Daytrana continues to bring important benefits to patients with ADHD, and sales of the product by Shire in the second quarter triggered the third and final $25 million milestone to Noven," said Brandt.
The addition of DAYTRANA, combined with the ADDERALL XR market share has helped Shire grow its total share of the US ADHD market to 28% at March 31, 2007 compared to 27% (which included a 1% share relating to ADDERALL) at March 31, 2006.
The depreciation and amortization charge for the year will be approximately 30% higher than the 2005 charge reflecting the acquisition of TKT and the amortization of milestone payments for DAYTRANA (prior guidance: 50% higher); and
The level of quarterly R&D expenditure is expected to increase over the Q2 2006 spend as we commence phase 3(b)/4 studies to support new product launches (including DAYTRANA, FOSRENOL and MESAVANCE);
In both the phase II and phase III studies, DAYTRANA was generally well tolerated during both the dose optimization and double-blind phases.
Because this voluntary recall is not due to product safety issues, all DAYTRANA patches, including those in the lots listed above, can continue to be used unless the release liner cannot be removed, or the patches are damaged while being opened.
The gain on sale of product rights also included the gain on re-measurement of the contingent consideration receivable relating to the divestment of DAYTRANA.
The FDA reviewed 51 cases of chemical leukoderma associated with the Daytrana patch (methylphenidate transdermal system) reported to the FDA Adverse Event Reporting System (FAERS) database and described in the medical literature from April 2006 to December 2014.
and Daytrana (methylphenidate transdermal system), the first and only patch approved for the treatment of ADHD.
The ruling applies to 15 products: Adderall tablets, Adderall XR extended-release capsules, Concerta extended-release tablets, Daytrana transdermal system, Desoxyn tablets, Dexedrine Spansule capsules and tablets, Focalin tablets, Focalin XR extended-release capsules, Metadate CD extended-release capsules, Methylin oral solution, Methylin chewable tablets, Ritalin tablets, Ritalin SR sustained-release tablets, Ritalin LA extended-release capsules, and Strattera capsules.
Daytrana offers true all-day therapy," asserts Noven Pharmaceuticals Vice-President Joseph Jones (Noven manufactures Daytrana for Shire, plc).
Daytrana is a once daily treatment containing the drug methylphenidate, a central nervous system (CNS) stimulant.
Basingstoke-based Shire revealed the US Food and Drug Administration had approved Daytrana as a treatment for attention deficit hyperactivity disorder.
Food and Drug Administration (FDA) for DAYTRANA (methylphenidate transdermal system), an investigational transdermal patch formulation for methylphenidate designed for once-daily use to treat attention deficit hyperactivity disorder (ADHD) in children aged 6 to 12 years.